Ascend Wellness Holdings (AAWH) Non-Current Deferred Tax Liability (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Non-Current Deferred Tax Liability came in at $20.2 million in Q1 2026, down 14.17% year-on-year from $23.5 million in Q1 2025, and down 6.15% quarter-over-quarter from $21.5 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Non-Current Deferred Tax Liability history runs 7 years deep, the most recent figure standing at $20.2 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 14.17% year-over-year to $20.2 million in Q1 2026; TTM through Mar 2026 was $20.2 million, a 14.17% decrease from a year earlier, with the FY2025 full-year figure at $21.5 million, down 8.21% from the prior year.
  • Non-Current Deferred Tax Liability eased to $20.2 million in Q1 2026 per AAWH's latest filing, from $21.5 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $110.6 million in Q4 2023 and bottomed at $276000.0 in Q1 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $25.6 million (2024), against an average of $30.8 million.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 11292.03% in 2023 and tumbled 78.81% in 2024, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $33.6 million in 2022, then jumped by 229.18% to $110.6 million in 2023, then tumbled by 78.81% to $23.4 million in 2024, then slipped by 8.21% to $21.5 million in 2025, then slipped by 6.15% to $20.2 million in 2026.
  • Per Business Quant, the three latest AAWH Non-Current Deferred Tax Liability figures stand at $20.2 million (Q1 2026), $21.5 million (Q4 2025), and $18.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.19 Mn
Mar 31, 2026 20.19 Mn
Dec 31, 2025 21.52 Mn
Dec 31, 2025 21.52 Mn
Sep 30, 2025 18.74 Mn
Sep 30, 2025 18.74 Mn
Jun 30, 2025 20.92 Mn
Jun 30, 2025 20.92 Mn
Mar 31, 2025 23.53 Mn
Mar 31, 2025 23.53 Mn
Dec 31, 2024 23.44 Mn
Dec 31, 2024 23.44 Mn
Sep 30, 2024 25.57 Mn
Sep 30, 2024 25.57 Mn
Jun 30, 2024 30.27 Mn
Jun 30, 2024 30.27 Mn
Mar 31, 2024 32.48 Mn
Mar 31, 2024 32.48 Mn
Dec 31, 2023 110.63 Mn
Dec 31, 2023 110.63 Mn